Creighton Diabetes Center — Omaha, Nebraska

Creighton Diabetes Center is a clinical research site located in Omaha, Nebraska, United States 68131.

Crixeo Health Trust Score: 84/100 (GOOD). This profile has not yet been claimed by the site owner.

Creighton Diabetes Center has participated in 22 clinical trials.

Therapeutic areas: Diabetes Type 2, Type 2 Diabetes, Pain.

Sponsors: Mannkind Corporation, DiObex, Avanir Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 84/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Creighton Diabetes Center?

Creighton Diabetes Center has a Crixeo Trust Score of 84/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Creighton Diabetes Center conducted?

Creighton Diabetes Center has 22 clinical trials on record. Their work covers Diabetes Type 2, Type 2 Diabetes, Pain.

Is Creighton Diabetes Center accredited by Crixeo Health?

Yes — Creighton Diabetes Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Creighton Diabetes Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.